MALLINCKRODT INC. V. WATSON LABORATORIES, INC.-FLORIDA

  1. January 25, 2012

    Covidien Makes Deal With Watson To Allow Generic Exalgo

    Zalicus Inc. on Wednesday said Covidien PLC, with which it partners on Covidien's painkiller Exalgo, has agreed to a settlement with Watson Pharmaceuticals Inc. that will allow a generic version of Exalgo to hit the market before the expiration of Covidien's patent.

  2. December 15, 2010

    Covidien Unit Targets Watson Over Generic Exalgo

    A Covidien PLC subsidiary has sued specialty pharmaceutical company Watson Pharmaceuticals Inc. in an effort to stop it from marketing a generic version of painkiller Exalgo.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!